Delcath Systems Inc (DCTH NASDAQ) stock market data APIs
$8.6413
0.2(2.3%)
as of November 17, 2025
Try our APIs with
free plan!
Delcath Systems Inc Financial Data Overview
Price chart is built with
Anychart
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. It also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. The company was founded in 1987 and is headquartered in New York, New York.
Prev. Close
8.6413
Open
8.8414
High
8.9546
Low
8.6263
52 wk Range
8.33-18.23
Market Cap
315 M
P/E Ratio
297.6667
Shares Outstanding
35 314 K
Revenue
79 603 K
EPS
0.02
Beta
0.405
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Delcath Systems Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Delcath Systems Inc data using free add-ons & libraries
Get Delcath Systems Inc Fundamental Data
Delcath Systems Inc Fundamental data includes:
- Net Revenue: 79 603 K
- EBITDA: 6 079 K
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-04
- EPS/Forecast: -0.03
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Delcath Systems Inc News
New
Short Sellers Are Targeting Small-Caps. Megacaps Are Getting a Pass.
Small-cap healthcare and midsize consumer names are in the crosshairs. Investors need to be very careful. Continue Reading View Comments
Delcath Stock Drops 5% After Preliminary Q3 Results And Full-Year Outlook Cut
(RTTNews) - Delcath Systems, Inc. (DCTH) fell 5.35% to $11.33, down $0.64, after reporting preliminary third-quarter 2025 results and trimming its full-year revenue guidance. For full year, Delcath n...
Delcath Systems reports $20.5M Q3 revenue, lowers FY revenue guidance
[Preliminary] moxiecreative Delcath Systems (NASDAQ:DCTH [https://seekingalpha.com/symbol/DCTH]) announced strong preliminary financial results [https://seekingalpha.com/pr/20270980-delcath-systems-a...
Here are the major earnings before the open Monday
Major earnings expected before the bell on Monday include: * Cleveland-Cliffs (CLF [https://seekingalpha.com/symbol/CLF]) * Dynex Capital (DX [https://seekingalpha.com/symbol/DX]) * Delcath Sys...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
